A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

None had been diagnosed with Alzheimer disease and related dementias at the start of the study. The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of ...

In the second study, a team led by Allie Seminer ... effects and that they are not guaranteed to prevent dementia." Newsweek has contacted Ozempic manufacturer Novo Nordisk for comment.

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, ...

Ozempic and Similar Drugs Could Help Ward Off Dementia, Study Suggests According to the study researchers, however, there’s still a lot we don’t know about exactly how GLP-1 drugs change ...